129 related articles for article (PubMed ID: 32454667)
1. Design and Development of Crystallo-co-agglomerates of Ritonavir for the Improvement of Physicochemical Properties.
Mahajan NM; Malghade AD; Dumore NG; Thenge RR
Turk J Pharm Sci; 2018 Dec; 15(3):248-255. PubMed ID: 32454667
[TBL] [Abstract][Full Text] [Related]
2. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
3. Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation.
Deshkar SS; Borde GR; Kale RN; Waghmare BA; Thomas AB
Int J Pharm Investig; 2017; 7(4):164-173. PubMed ID: 29692975
[TBL] [Abstract][Full Text] [Related]
4. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
Pandey S; Patil AT
Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
[TBL] [Abstract][Full Text] [Related]
5. Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique.
Nokhodchi A; Maghsoodi M
AAPS PharmSciTech; 2008; 9(1):54-9. PubMed ID: 18446461
[TBL] [Abstract][Full Text] [Related]
6. Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.
Garala K; Patel J; Patel A; Raval M; Dharamsi A
Int J Pharm Investig; 2012 Oct; 2(4):189-200. PubMed ID: 23580935
[TBL] [Abstract][Full Text] [Related]
7. Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability.
Raval MK; Sorathiya KR; Chauhan NP; Patel JM; Parikh RK; Sheth NR
Drug Dev Ind Pharm; 2013 Mar; 39(3):437-46. PubMed ID: 22380546
[TBL] [Abstract][Full Text] [Related]
8. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
9. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
[TBL] [Abstract][Full Text] [Related]
10. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
Gupta VR; Mutalik S; Patel MM; Jani GK
Acta Pharm; 2007 Jun; 57(2):173-84. PubMed ID: 17507314
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design.
Garala KC; Patel JM; Dhingani AP; Dharamsi AT
Int J Pharm; 2013 Aug; 452(1-2):135-56. PubMed ID: 23684660
[TBL] [Abstract][Full Text] [Related]
12. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
[TBL] [Abstract][Full Text] [Related]
13. Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique.
Pawar A; Paradkar A; Kadam S; Mahadik K
AAPS PharmSciTech; 2004 Sep; 5(4):e55. PubMed ID: 15760052
[TBL] [Abstract][Full Text] [Related]
14. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design.
Gaikwad VL; Jadhav NR; Pawar AP; Mahadik KR
AAPS PharmSciTech; 2019 May; 20(5):192. PubMed ID: 31115715
[TBL] [Abstract][Full Text] [Related]
15. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
Dalvadi H; Parmar K; Yadav S
Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
[TBL] [Abstract][Full Text] [Related]
16. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
[TBL] [Abstract][Full Text] [Related]
17. A New Crystal Engineering Technique for Dissolution Enhancement of Poorly Soluble Drugs Combining Quasi-emulsion and Crystallo-co Agglomeration Methods.
Makar RR; Latif R; Hosni EA; El Gazayerly ON
Iran J Pharm Res; 2020; 19(2):219-235. PubMed ID: 33224227
[TBL] [Abstract][Full Text] [Related]
18. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
Maghsoodi M
Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
[TBL] [Abstract][Full Text] [Related]
19. An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30.
Tapas A; Kawtikwar P; Sakarkar D
Acta Pol Pharm; 2012; 69(2):299-308. PubMed ID: 22568045
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
Maghsoodi M; Tajalli Bakhsh AS
Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
